Clexio Biosciences Employee Directory

Clexio Biosciences corporate office is located in Northern High-Tech Park 10 Hakidma, Yokne'am, Northern District, Israel and has 11-50 employees.

Employees by Department

Departments

Number of employees

Finance

2

Medical & Health

2

C-Suite

1

Operations

1

Clexio Biosciences CEO

Elisabeth Kogan, Chief Executive Officer & Co-Founder at Clexio Biosciences
Israel flag for contact location.
Elisabeth KoganChief Executive Officer & Co-Founder
PhonePhoneEmailEmail
See Profile

Key Employees of Clexio Biosciences

Clexio Biosciences Global Presence

globalPresence illustration
Asia1-10

Index of contact profiles from Clexio Biosciences

Hundreds of professionals searching for Clexio Biosciences have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Clexio Biosciences

Explore people who held key positions, contributed to Clexio Biosciences's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Israel

Frequently Asked Questions Regarding Clexio Biosciences Employees

How many employees does Clexio Biosciences have?
Clexio Biosciences has 11-50 employees
Who is the CEO of Clexio Biosciences?
Clexio Biosciences’s CEO is Elisabeth Kogan
Who are Clexio Biosciences key employees?
Some of Clexio Biosciences key employees are Yifat Ronen-Protas, Hila Mark
Where is Clexio Biosciences located?
Clexio Biosciences’s headquarters are located at Northern High-Tech Park 10 Hakidma, Yokne'am, Northern District, Israel
How do I contact Clexio Biosciences?
Clexio Biosciences Contact Info: Website: www.clexio.com
What does Clexio Biosciences do?

Clexio Biosciences is a clinical-stage company focused on developing innovative drugs and technologies for patients with Central Nervous System disorders, particularly Major Depressive Disorder (MDD) and Epilepsy. Their lead drug candidate, CLE-100, is currently undergoing Phase 2 clinical trials in the United States, while a second candidate, CLE-... 043, is in preclinical development. The company aims to address the unmet needs of patients who have not responded to existing treatments. Clexio's multi-asset pipeline reflects their commitment to advancing novel therapies in neuropsychiatry.Read More

Is Clexio Biosciences a public company?
Clexio Biosciences is private company therefore does not currently have an official ticker symbol
See more information about Clexio Biosciences Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.